Quanttus combines clinical-grade vital-sign monitoring with contextual analysis to create wearable technologies and companion applications that provide real-time personalized health insights. Its wearables capture and analyze more than half a million vital-sign data points per day; the platform comprises devices and apps that translate that data into actionable insights. The company was developed by a team with backgrounds at MIT, Nike, Apple, IDEO, and Massachusetts General Hospital and is led by CEO and co-founder Shahid Azim. Quanttus targets use cases ranging from cardiac disease and hypertension monitoring to stress and general wellness. The company says it will further validate its continuous monitoring approach and bring products to market. It will use the recent funding to continue developing breakthroughs in clinical-grade monitoring and advances in contextual analysis.

Total raised

$19M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2014